{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:38:51Z","timestamp":1793385531038,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.toxlet.2014.12.007","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T17:51:41Z","timestamp":1418406701000},"page":"590-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine"],"prefix":"10.1016","volume":"232","author":[{"given":"Nasim","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-0544","authenticated-orcid":false,"given":"Hossein","family":"Hassanian-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Haghparast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Shadnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Hashemi Demaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Assar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2014.12.007_bib0005","unstructured":"Davis, C.P., 2014. Narcan side effects center. http:\/\/www.rxlist.com\/narcan-side-effects-drug-center-htm (accessed 16.03.14.)."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0010","unstructured":"Drugs.com, 2014. Buprenorphine. Retrieved from: http:\/\/www.drugs.com\/cdi\/buprenorphine.html (accessed 26.09.14.)."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-8993(98)01029-4","article-title":"Morphine tolerance and dependence in the nucleus paragiganto cellularis: single unit recording study in vivo","volume":"814","author":"Haghparast","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0960327112450901","article-title":"Withdrawal syndrome caused by naltrexone in opioid abusers","volume":"33","author":"Hassanian-Moghaddam","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0025","first-page":"534","article-title":"Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011","volume":"17","author":"Hassanian-Moghaddam","year":"2014","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0030","series-title":"Goldfrank\u2019s Toxicologic Emergencies","first-page":"579","article-title":"Opioid antagonists","author":"Howland","year":"2011"},{"key":"10.1016\/j.toxlet.2014.12.007_bib0035","series-title":"Goldfrank\u2019s Toxicologic Emergencies","first-page":"559","article-title":"Opioids","author":"Nelson","year":"2011"},{"key":"10.1016\/j.toxlet.2014.12.007_bib0040","unstructured":"RB Pharmaceuticals, 2014. Suboxone tablets 8mg\/2mg. Retrieved from: http:\/\/www.medicines.org.uk\/emc\/medicine\/26225 (accessed 26.09.14.)."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0045","unstructured":"U.S. Food and Drug, (2013). Subutex (buprenorphine hydrochloride) and Suboxone tablets (buprenorphine hydrochloride and naloxone hydrochloride). Retrieved from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm191520.htm (accessed 26.09.14.)."},{"key":"10.1016\/j.toxlet.2014.12.007_bib0050","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1360-0443.2008.02244.x","article-title":"A case of heroin overdose reversed by sublingually administered buprenorphine\/naloxone (Suboxone)","volume":"103","author":"Welsh","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.toxlet.2014.12.007_bib0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5055\/jom.2012.0098","article-title":"Intravenous use of illicit buprenorphine\/naloxone to reverse and acute heroin overdose","volume":"8","author":"Yokell","year":"2012","journal-title":"J. Opioid Manage."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427414015148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427414015148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:26:06Z","timestamp":1537997166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427414015148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0378427414015148"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2014.12.007","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}